SC
AXSM icon

Siena Capital’s Axsome Therapeutics AXSM Stock Holding History

Siena Capital’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Hold
2
– – ﹤0.01% 167
2022
Q2 		$0 Sell
2
-13
-87% -$411 ﹤0.01% 227
2022
Q1 		$1K Buy
+15
New +$465 ﹤0.01% 270

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Siena Capital's AXSM Position: Q3 2022 in Review

Siena Capital held its Axsome Therapeutics (AXSM) position steady in Q3 2022 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #167.

Siena Capital first reported a position in AXSM in Q1 2022 and has held it in 3 quarters since. The position peaked at $1K in Q1 2022. 189 funds tracked by Wall St. Rank hold AXSM as of Q3 2022.

  • Siena Capital held 2 shares of Axsome Therapeutics worth $0 as of Q3 2022.
  • Siena Capital left its Axsome Therapeutics share count unchanged in Q3 2022.
  • Axsome Therapeutics made up ﹤0.01% of Siena Capital's portfolio in Q3 2022, its #167 holding.
  • Siena Capital first reported a position in Axsome Therapeutics in Q1 2022 and has held it in 3 quarters since.
  • Siena Capital's Axsome Therapeutics position peaked at $1K in Q1 2022.
  • 189 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2022.

Based on Siena Capital's 13F filing for Q3 2022, filed 2 Nov 2022.